Off-Label Drug Promotion: Pharmaceutical Companies Selling Drugs for Unapproved Uses

How pharmaceutical companies have paid over $35 billion in fines and settlements for illegally marketing drugs for uses the FDA never approved; putting patients at risk while generating billions in off-label revenue